Results 121 to 130 of about 24,311 (208)

Deceptive beauty of non-natural structures. [PDF]

Protein Sci
Gurevich VV, Gurevich EV.
europepmc   +1 more source

Indole Alkaloids as Biased Opioid Receptor Modulators. [PDF]

Pharmaceuticals (Basel)
Grundmann O, Henderson A.
europepmc   +1 more source

Protease-activated receptor 1 as an endogenous model of peptidergic Gαq-Gα12-biased G protein signaling. [PDF]

Front Mol Biosci
Fallon BS, Campbell RA, English JG.
europepmc   +1 more source

Signaling Bias as a Framework for Therapeutically Relevant Orthosteric Agonists: The β₂ Adrenergic Receptor Paradigm. [PDF]

Biochemistry
Georgiou K, Kolocouris A.
europepmc   +1 more source

Decoding GPCR signaling in living cells to advance early therapeutic discovery for neurological disorders. [PDF]

Front Mol Neurosci
Palladino G, Patarra R, Li Z, Rossner MJ, Wehr MC.   +4 more
europepmc   +1 more source

Multilevel Genetic and Functional Assessment of an ARR3 Frameshift Variant in Early-Onset High Myopia. [PDF]

Int J Genomics
Li Y, Teng F, Zhu Q, Cui S, Yang W, Ma P.   +5 more
europepmc   +1 more source

Phosphoregulation of the novel hemi-arrestin MAPK scaffold Sms1 prevents untimely mating. [PDF]

Nat Commun
Sieber B, Merlini L, Li W, Besomi M, Michon L, Gordon-Lennox S, Martin SG.   +6 more
europepmc   +1 more source

Cannabinoid-Driven Rewiring of GPCR and Ion Channel Signaling in Lung Cancer. [PDF]

Biomedicines
Heriyanto DS, Nurkolis F, Choi J, Park S, Choi M, Tjandrawinata RR, Rani A, Park MN, Kwak MJ, Shim BS, Kim B.   +10 more
europepmc   +1 more source

Immunomodulatory crosstalk between GPCR and hippo signaling in cancer: implications for tumor immunity and therapeutic targeting. [PDF]

Front Immunol
Ren X, Xie T, Liu L, Jin X, Zhang M.
europepmc   +1 more source

Modelling G protein-biased agonism using GLP-1 receptor C-terminal mutations. [PDF]

Mol Metab
Tran HD, Zuo Y, Wong C, Pollard A, Bloom S, Jones B.   +5 more
europepmc   +1 more source